Skip to main content
OpenTrials

Clinical trial condition

Respiratory Tract Diseases

Explore clinical trials studying Respiratory Tract Diseases. Study availability and eligibility vary by location and protocol.

37,292 public trials 4,949 recruiting studies
Refine in advanced search Browse all conditions

Respiratory Tract Diseases trial results

Recruiting

A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer

NCT05498428

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University of California at San Diego La Jolla, California, United States
  • University of California Irvine Orange, California, United States
  • Stanford Cancer Institute Stanford, California, United States
  • Johns Hopkins Office of Capital Region Research - Sibley Memorial Hospital Washington D.C., District of Columbia, United States
View all 110 locations
View Trial Details
Recruiting

A Study of Clinical Outcomes in Participants With EGFR Mutated Advanced Non-Small Cell Lung Cancer (NSCLC) in a Real-World Setting

NCT07230691

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • University Hospital Graz Graz, Austria
  • Klinikum Klagenfurt am Worthersee Klagenfurt, Austria
  • UZ Brussel Brussels, Belgium
  • UZ Antwerpen Edegem, Belgium
View all 85 locations
View Trial Details
Recruiting

A Study of Amivantamab and Olomorasib Combination Therapy in Participants With Metastatic Non-Small Cell Lung Cancer

NCT07227025

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • New York University Langone Medical Center New York, United States
  • Oncology Consultants Cancer Center Houston, Texas, United States
  • Virginia Cancer Specialists Fairfax, Virginia, United States
  • Princess Margaret Hospital Toronto, Ontario, Canada
View all 13 locations
View Trial Details
Recruiting

Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer

NCT07057791

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive Stage Lung Small Cell Cancer, +8 more
Locations
  • University of Miami Miami, Florida, United States
  • University of Maryland Baltimore, Maryland, United States
  • Morristown Medical Center Morristown, New Jersey, United States
  • Rutgers Cancer Institute New Brunswick, New Jersey, United States
View all 13 locations
View Trial Details
Recruiting

A Study of JNJ-90301900 in Combination With Chemoradiation Followed by Consolidation Immunotherapy for Non-Small Cell Lung Cancer (NSCLC)

NCT06667908

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Moores Cancer Center at UC San Diego Health La Jolla, California, United States
  • University of Connecticut Health Center Farmington, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
  • University of Miami Miami, Florida, United States
View all 43 locations
View Trial Details
Recruiting

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

NCT06951217

Conditions
Idiopathic Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF), Lung Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • University of Southern California Los Angeles, California, United States
  • University of Colorado, Anschutz Medical Campus Aurora, Colorado, United States
  • Renstar Medical Research Ocala, Florida, United States
View all 72 locations
View Trial Details

Related conditions